H. Taskaynatan, Y. Cankurtaran, Y. Kucukzeybek, A. Alacacıoğlu, Y. Yildiz, T. Salman, U. Oflazoğlu, U. Varol, Seray Sever, M. Tarhan
{"title":"每三周评估一次蒽环类药物加环磷酰胺,随后是每周紫杉醇的疗效和毒性:Izmır肿瘤组(IZOG)研究","authors":"H. Taskaynatan, Y. Cankurtaran, Y. Kucukzeybek, A. Alacacıoğlu, Y. Yildiz, T. Salman, U. Oflazoğlu, U. Varol, Seray Sever, M. Tarhan","doi":"10.5505/aot.2019.05668","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":435847,"journal":{"name":"Acta Oncologica Turcica","volume":"99 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Evaluation of efficacy and toxicity of anthracycline plus cyclophosphamide every three weeks followed by weekly paclitaxel: The Izmır Oncology Group (IZOG) Study\",\"authors\":\"H. Taskaynatan, Y. Cankurtaran, Y. Kucukzeybek, A. Alacacıoğlu, Y. Yildiz, T. Salman, U. Oflazoğlu, U. Varol, Seray Sever, M. Tarhan\",\"doi\":\"10.5505/aot.2019.05668\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":435847,\"journal\":{\"name\":\"Acta Oncologica Turcica\",\"volume\":\"99 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1900-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Acta Oncologica Turcica\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5505/aot.2019.05668\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Oncologica Turcica","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5505/aot.2019.05668","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Evaluation of efficacy and toxicity of anthracycline plus cyclophosphamide every three weeks followed by weekly paclitaxel: The Izmır Oncology Group (IZOG) Study